方浩
-
教授
博士生导师
硕士生导师
- 主要任职:山东大学药学院药物化学研究所教授、博士生导师
- 性别:男
- 毕业院校:中国药科大学
- 学历:博士研究生毕业
- 学位:博士生
- 在职信息:在职
- 所在单位:药学院
- 入职时间: 2004-12-23
- 学科:药物化学
- 电子邮箱:haofangcn@sdu.edu.cn
访问量:
-
[1]
Liu, Meng.
Discovery of a Novel Benzimidazole Derivative Targeting Histone Deacetylase to Induce Ferroptosis an.
Journal of Medicianal Chemistry,
2024.
-
[2]
邱雪婷.
An in-line method for high-throughput screening of protein tyrosine phosphatase receptor type O inhi.
Journal of chromatography A,
1713,
2024.
-
[3]
.
Discovery of benzofuran-2-carboxylic acid derivatives as lymphoid tyrosine phosphatase (LYP) inhibit.
EUR J MED CHEM,
2023.
-
[4]
聂义明.
Development of QSRR model for hydroxamic acids using PCA-GA-BP algorithm incorporated with molecular.
FRONTIERS IN CHEMISTRY,
2022.
-
[5]
Liang, Xiao.
Design, synthesis and biological evaluation of hydantoin derivatives as Mcl-1 selective inhibitors.
Bioorganic Chemistry,
121,
105643,
2022.
-
[6]
侯旭奔.
Discovery of Novel Src Homology-2 Domain-Containing Phosphatase 2 and Histone Deacetylase Dual Inhib.
Journal of Medicinal Chemistry,
2022.
-
[7]
侯旭奔.
PTPRO is a therapeutic target and correlated with immune infiltrates in pancreatic cancer.
Journal of Cancer,
12,
7445-7453,
2021.
-
[8]
梁翰之.
Structure-Based Design of 2-Aminopurine Derivatives as CDK2 Inhibitors for Triple-Negative Breast Ca.
FRONT PHARMACOL,
13,
864342,
2022.
-
[9]
汪铃.
Boronate-Based Fluorescent Probes as a Prominent Tool for H2 O2 Sensing and Recognition.
Curr Med Chem,
29,
2476-2489,
2022.
-
[10]
刘蒙.
Strategies to overcome drug resistance using SHP2 inhibitors.
ACTA PHARMACEUTICA SINICA B,
11,
3908,
2021.
-
[11]
Reham M Elhassan.
Recent advances in the development of allosteric protein tyrosine phosphatase inhibitors for drug di.
Medicinal Research Reviews,
42,
1064,
2022.
-
[12]
陈晨.
Discovery of DNA-Targeting HDAC Inhibitors with Potent Antitumor Efficacy In Vivo That Trigger Antit.
Journal of Medicinal Chemistry,
65,
3667,
2022.
-
[13]
梁涛.
Design, synthesis and biological evaluation of 3, 4-disubstituted-imidazolidine-2, 5-dione derivativ.
European Journal of Medicinal Chemistry,
221,
2021.
-
[14]
梁涛.
Design, synthesis and biological evaluation of 3, 4-disubstituted-imidazolidine-2, 5-dione derivativ.
European Journal of Medicinal Chemistry,
221,
2021.
-
[15]
李雯.
Photopharmacology-based small-molecule proteolysis targeting chimeras: optical control of protein de.
Future Medicinal Chemistry,
12,
1991,
2020.
-
[16]
Lu, Wanzhen.
A novel selective histone deacetylase I inhibitor CC-4a activates latent HIV-1 through NF-kappa B pa.
Life Sciences,
267,
2021.
-
[17]
郭永真.
Recent Applications of Benzimidazole as a Privileged Scaffold in Drug Discovery.
Mini-Reviews in Medicinal Chemistry,
21,
1367,
2021.
-
[18]
李雯.
Recent Advances in Small Molecule PROTACs for the Treatment of Cancer.
Current Medicinal Chemistry,
28,
4893,
2021.
-
[19]
赵雲鹏.
Recent Development of Novel HDAC6 Isoform-selective Inhibitors.
Current Medicinal Chemistry,
28,
4133,
2021.
-
[20]
梁涛.
Potential applications of BPFP1 in Bcl-2 protein quantification, carcinoma cell visualization, cell .
European journal of medicinal chemistry,
2021.